One of the basic concepts in quantum mechanics is that it is impossible to observe physical objects without affecting them in a significant way; there can be no measurement without disturbance. In 1927, theoretical physicist Werner Heisenberg claimed that this fact could be expressed as an uncertainty relation, describing a reciprocal relation between the accuracy in position and the disturbance in momentum. [ + ]

Trajan has made a number of key appointments to its leadership team. [ + ]

The first Telethon-Perth Children's Hospital Research Fund has provided the impetus for 17 projects. [ + ]

Visualising the structures of complex molecules is now a whole lot easier with a new toolkit. [ + ]

Wealth as a gift for the University of Western Australia. [ + ]

The 20 subjects enrolled in a trial of the HSV-2 vaccine under development at Allied Healthcare's (ASX:AHZ) Coridon have all received two out of three planned doses. [ + ]

Genea Biocells has produced human skeletal muscle from stem cells, in a breakthrough technique with potential applications in the treatment of muscular dystrophies. [ + ]

The Melanoma Genome Project is well underway with sequencing data submitted to the International Cancer Genome Consortium repository and expectations this will be publicly available early next year. [ + ]

The Department of Health and Ageing has released draft technical guidelines for therapeutic services, open for consultation until 23 November 2013. [ + ]

Sydney-based uHealth will work with iSonea (ASX:ISN) to pursue more sales opportunities for the latter's asthma symptom monitoring device, AirSonea. [ + ]

The Centenary Institute's cytometry research program last night received the $1 million Ramaciotti Biomedical Research Award. As a result of the award, the Ramaciotti Centre for Human Systems Biology will be established. [ + ]

Qiagen has launched the Empowered Genome Community - an initiative to help people who have had their genomes sequenced share, explore and interpret their data with researchers and each other. [ + ]

Innate Immunotherapeutics has moved its base from Auckland to Sydney as it prepares for Australian phase IIb trials of SPMS treatment candidate MIS416. [ + ]

The 2013 recipients of the biennial Ramaciotti Awards for biomedical research have been announced. [ + ]

Results from a pilot trial of Ellex Medical Lasers' (ASX:ELX) Retinal Rejuvenation Therapy (2RT) suggest the treatment could act as an early intervention therapy for AMD. [ + ]